These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15637150)

  • 41. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
    Munster PN; Troso-Sandoval T; Rosen N; Rifkind R; Marks PA; Richon VM
    Cancer Res; 2001 Dec; 61(23):8492-7. PubMed ID: 11731433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
    Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
    Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
    Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
    Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
    Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
    Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor.
    Xu W; Ngo L; Perez G; Dokmanovic M; Marks PA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15540-5. PubMed ID: 17030815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
    Nishioka C; Ikezoe T; Yang J; Komatsu N; Bandobashi K; Taniguchi A; Kuwayama Y; Togitani K; Koeffler HP; Taguchi H
    Leuk Res; 2008 Feb; 32(2):287-96. PubMed ID: 17644177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
    Koyama M; Izutani Y; Goda AE; Matsui TA; Horinaka M; Tomosugi M; Fujiwara J; Nakamura Y; Wakada M; Yogosawa S; Sowa Y; Sakai T
    Clin Cancer Res; 2010 Apr; 16(8):2320-32. PubMed ID: 20371690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells.
    De los Santos M; Martínez-Iglesias O; Aranda A
    Endocr Relat Cancer; 2007 Dec; 14(4):1021-8. PubMed ID: 18045953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
    Butler LM; Agus DB; Scher HI; Higgins B; Rose A; Cordon-Cardo C; Thaler HT; Rifkind RA; Marks PA; Richon VM
    Cancer Res; 2000 Sep; 60(18):5165-70. PubMed ID: 11016644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP.
    Venza I; Visalli M; Oteri R; Teti D; Venza M
    Int Immunopharmacol; 2014 Aug; 21(2):439-46. PubMed ID: 24946096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells.
    Sanda T; Okamoto T; Uchida Y; Nakagawa H; Iida S; Kayukawa S; Suzuki T; Oshizawa T; Suzuki T; Miyata N; Ueda R
    Leukemia; 2007 Nov; 21(11):2344-53. PubMed ID: 17690692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SAHA-sensitized prostate cancer cells to TNFalpha-related apoptosis-inducing ligand (TRAIL): mechanisms leading to synergistic apoptosis.
    Lakshmikanthan V; Kaddour-Djebbar I; Lewis RW; Kumar MV
    Int J Cancer; 2006 Jul; 119(1):221-8. PubMed ID: 16450389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitors: Potential in cancer therapy.
    Marks PA; Xu WS
    J Cell Biochem; 2009 Jul; 107(4):600-8. PubMed ID: 19459166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction.
    Choudhary S; Wang HC
    J Cancer Res Clin Oncol; 2009 Nov; 135(11):1601-13. PubMed ID: 19506904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells.
    Di Bernardo G; Alessio N; Dell'Aversana C; Casale F; Teti D; Cipollaro M; Altucci L; Galderisi U
    J Cell Physiol; 2010 Nov; 225(2):537-44. PubMed ID: 20458754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes.
    Kiweler N; Wünsch D; Wirth M; Mahendrarajah N; Schneider G; Stauber RH; Brenner W; Butter F; Krämer OH
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):343-356. PubMed ID: 31932908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells.
    Gao S; Mobley A; Miller C; Boklan J; Chandra J
    Leuk Res; 2008 May; 32(5):771-80. PubMed ID: 18031811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.
    Prasad P; Vasquez H; Das CM; Gopalakrishnan V; Wolff JE
    J Neurooncol; 2009 Feb; 91(3):279-86. PubMed ID: 18853233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.